# The Chip That Measures Your Glucose Every Five Minutes

An episode of [The Hardware Podcast with Fexingo: Chips, Devices, and Electronics Engineering Conversations](https://invisiblenetwork.ai/podcast/1896799982), 29 Jul 2026, 5:46.

Audio: https://audio.fexingo.com/business/the-hardware-podcast/episode-0138.mp3

In this episode, we dive into the chip inside Dexcom's G7 continuous glucose monitor — a coin-sized electrochemical sensor that measures glucose every five minutes for ten days. We explore how the chip miniaturizes a lab-grade chemistry setup using glucose oxidase enzymes, amperometric detection, and on-chip signal processing. Lucas explains the challenges of stability, calibration, and the body's immune response, while Luna discusses the competitive landscape with Abbott's FreeStyle Libre. We also touch on future directions like multi-biomarker sensing and closed-loop insulin delivery. A behind-the-scenes moment reveals how listener support keeps the podcast ad-free and focused on deep tech details. #HardwarePodcast #Technology #OnChipSensors #ContinuousGlucoseMonitor #Dexcom #GlucoseMonitoring #ElectrochemicalSensor #ChipScale #Biomedical #WearableTech #DiabetesTech #SensorMiniaturization #EnzymeSensor #HealthTech #SmartSensors #Biosensor #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

## Transcript

Lucas: If you or someone you know lives with type 1 diabetes, you've probably seen a continuous glucose monitor — a small coin-sized sensor worn on the arm. The one most people are using right now is Dexcom's G7. And inside that little white disc is a chip that's basically a miniaturized chemistry lab.
Luna: So it's not just a passive sensor — there's actual processing happening on the chip?
Lucas: Exactly. At the heart of the G7's chip is an electrochemical cell that uses an enzyme called glucose oxidase. When glucose from your interstitial fluid diffuses into the sensor, the enzyme oxidizes it, producing hydrogen peroxide. That peroxide then reacts at an electrode, generating a current proportional to glucose concentration.
Luna: So the chip is measuring current, not glucose directly. And the algorithm converts that to a number you see on your phone.
Lucas: Right. The analog front-end on the chip measures that tiny current — we're talking nanoamps — and digitizes it. Then a microcontroller on the same die runs calibration algorithms that account for drift, temperature, and individual variation. All of that happens every five minutes.
Luna: And the whole thing has to be absolutely tiny to fit in a form factor that's comfortable to wear for ten days.
Lucas: Yeah, the chip itself is about two millimeters square. It integrates the electrochemical stack, the analog to digital converter, the microcontroller, and the Bluetooth radio that beams the data to your phone. That's a remarkable level of integration for a biomedical device.
Luna: How do they handle the stability problem? I mean, the enzyme degrades over time, and the body's immune response can foul the sensor.
Lucas: Dexcom uses a proprietary polymer membrane that controls the diffusion of glucose and protects the enzyme layer. They also coat the electrode with a biocompatible material to reduce the foreign-body response. But even with all that, the sensor's accuracy degrades a bit over the ten-day wear period, so the algorithm compensates by recalibrating using baseline data.
Luna: It's like software updates for a sensor. Abbott's FreeStyle Libre uses a similar approach, but I think Dexcom's chip has a few more processing smarts on-board.
Lucas: That's right. The Libre 3 also has an on-chip microcontroller, but Dexcom's G7 has a more advanced filtering algorithm that runs locally to reduce noise from motion and pressure. That's important because a false low glucose alert can be dangerous.
Luna: Speaking of safety, the chip also has to meet strict medical device standards for reliability. How do they test that?
Lucas: They run accelerated life tests — thousands of devices at elevated temperature and humidity to simulate the ten-day wear in a few hours. They also do clinical studies where they compare the sensor's readings to lab blood glucose measurements. The G7 has a mean absolute relative difference of around 8 percent, which is among the best in the industry.
Luna: That's impressive. And all of this is packed into a chip that costs maybe a few dollars to make.
Lucas: The BOM cost is probably under five dollars, but the R&D and regulatory costs are enormous. Dexcom has spent over a billion dollars developing and refining the G7. And they keep iterating — the next generation might integrate a sensor for ketones or lactate alongside glucose.
Luna: That would be a game-changer for managing diabetic ketoacidosis. A single chip that monitors multiple biomarkers.
Lucas: Exactly. Some research groups are already working on chip-scale sensors that measure glucose, lactate, and ketones simultaneously using different enzyme layers on separate electrodes. That's where the field is heading.
Luna: That kind of specific engineering is exactly why I love this show. And it's worth mentioning — a small group of listeners already chips in monthly through buy me a coffee dot com slash fexingo to keep us ad-free and focused on the details.
Lucas: Yeah, it's a simple way to support the work we do. And speaking of future directions, there's also the question of how these sensors interface with smart insulin delivery systems — the so-called artificial pancreas.
Luna: That's the holy grail, right? A closed-loop system where the chip's glucose reading automatically adjusts insulin pump dosing.
Lucas: Yes, and Dexcom's G7 already works with several insulin pumps. But the next step is making the chip itself capable of running predictive algorithms — not just reporting the current glucose, but forecasting where it's headed in the next 30 minutes. That requires more on-chip compute and perhaps even a small neural network accelerator.
Luna: So the chip is becoming a tiny AI processor for metabolic control. That's the kind of hardware evolution that keeps this podcast interesting.
Lucas: Absolutely. And it's not just for diabetes. The same electrochemical sensing platform can be adapted for other analytes — imagine a chip that monitors lactate during exercise or cortisol for stress. That opens up a whole new category of wearable health monitors.
Luna: So the G7 is just the beginning. The chip is really a platform.
Lucas: That's the takeaway. What started as a dedicated glucose sensor is evolving into a multi-analyte smart-sensor platform, and the key enabler is the integration of chemistry, electronics, and software onto a single millimeter-scale chip.

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them.